Showing results (11-20 of 129) with videos related to
Sort By:
Pageof 13
The Journal of Pharmacology and Experimental Therapeutics|January 13, 2005
The role of mitochondrial uncoupling in 3,4-methylenedioxymethamphetamine-mediated skeletal muscle hyperthermia and rhabdomyolysisDaniel E Rusyniak, Stephany L Tandy, S K Hekmatyar, et al.Clinical Toxicology (Philadelphia, Pa.)|July 9, 2008
Conservative management of elemental mercury retained in the appendixDaniel E Rusyniak, Kristine A NanagasHandbook of Clinical Neurology|November 22, 2018
Neuroleptic malignant syndrome and serotonin syndromeLaura M Tormoehlen, Daniel E RusyniakDrug Testing and Analysis|December 30, 2023
Influence of carbon side chain length on the in vivo pharmacokinetic and pharmacodynamic characteristics of illicitly manufactured fentanylsJeremy R Canfield, Jon E SpraguePharmacology, Biochemistry, and Behavior|May 7, 2026
The abuse-related effects of illicitly manufactured fentanyls (IMFs): A mini reviewJeremy R Canfield, Jon E SpragueArchives of Toxicology|October 17, 2024
In vivo pharmacokinetic, pharmacodynamic and brain concentration comparison of fentanyl and para-fluorofentanyl in ratsJeremy R Canfield, Jon E SpragueBasic & Clinical Pharmacology & Toxicology|August 24, 2016
The Pharmacology and Toxicology of the 'Holy Trinity'Joseph T Horsfall, Jon E SpragueChemical Research in Toxicology|March 9, 2016
Impact of Functional Group Modifications on Designer Phenethylamine Induced HyperthermiaGregory G Grecco, Jon E SpragueAddiction Biology|February 21, 2024
The dopamine 3 receptor as a candidate biomarker and therapeutic for opioid use disorderMatthew L Banks, Jon E SpraguePageof 13